Zealand Pharma A/S (CPH:ZEAL)
279.70
-0.80 (-0.29%)
At close: Mar 19, 2026
Zealand Pharma Employees
As of December 31, 2025, Zealand Pharma had 501 total employees, including 481 full-time and 20 part-time employees. The number of employees increased by 146 or 41.13% compared to the previous year.
Employees
501
Change
146
Growth
41.13%
Revenue / Employee
18.77M DKK
Profits / Employee
13.15M DKK
Market Cap
19.75B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 501 | 146 | 41.13% | 481 | 20 |
| Sep 30, 2025 | 440 | 142 | 47.65% | 440 | 0 |
| Jun 30, 2025 | 424 | 136 | 47.22% | 424 | 0 |
| Mar 31, 2025 | 385 | 115 | 42.59% | 385 | 0 |
| Dec 31, 2024 | 355 | 102 | 40.32% | 335 | 20 |
| Sep 30, 2024 | 298 | 49 | 19.68% | 298 | 0 |
| Jun 30, 2024 | 288 | 52 | 22.03% | 288 | 0 |
| Mar 31, 2024 | 270 | 50 | 22.73% | 270 | 0 |
| Dec 31, 2023 | 253 | 57 | 29.08% | 253 | 0 |
| Sep 30, 2023 | 249 | 46 | 22.66% | 249 | 0 |
| Jun 30, 2023 | 236 | -1 | -0.42% | 236 | 0 |
| Mar 31, 2023 | 220 | -125 | -36.23% | 220 | 0 |
| Dec 31, 2022 | 196 | -159 | -44.79% | 196 | 0 |
| Sep 30, 2022 | 203 | -143 | -41.33% | 203 | 0 |
| Jun 30, 2022 | 237 | -98 | -29.25% | 237 | 0 |
| Mar 31, 2022 | 345 | 10 | 2.99% | 345 | 0 |
| Dec 31, 2021 | 355 | 26 | 7.90% | 355 | 0 |
| Sep 30, 2021 | 346 | 17 | 5.17% | 346 | 0 |
| Mar 31, 2021 | 335 | 144 | 75.39% | 335 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Demant | 26,704 |
| Coloplast | 16,983 |
| GN Store Nord | 7,371 |
| Ambu A/S | 5,200 |
| H. Lundbeck | 5,039 |
| Embla Medical | 4,195 |
| Genmab | 2,973 |
Zealand Pharma News
- 8 days ago - Zealand Pharma A/S at Barclays Global Healthcare Conference Transcript - GuruFocus
- 10 days ago - Zealand Pharma to participate in upcoming investor conferences in March 2026 - GlobeNewsWire
- 13 days ago - Disappointing weight-loss-trial results from Zealand Pharma sends shares tumbling - Market Watch
- 13 days ago - Roche's Obesity Drug Shows Promise But Trails GLP-1 Giants Novo Nordisk, Eli Lilly - Benzinga
- 13 days ago - Zealand Pharma slump wipes billions off its value after obesity drug data disappoints - Reuters
- 13 days ago - Roche, Zealand Pharma Obesity Drug Hits Goal in Midstage Trial - WSJ
- 14 days ago - Zealand Pharma announces positive Phase 2 results for petrelintide, an amylin analog with potential to redefine the weight management experience for people living with overweight and obesity - GlobeNewsWire
- 4 weeks ago - Q4 2025 Zealand Pharma A/S Earnings Call Transcript - GuruFocus